Yasushi Tsuji

TAS-102 monotherapy for pretreated metastatic colorectal cancer: a double-blind, randomised, placebo-controlled phase 2 trial

Takayuki Yoshino, Nobuyuki Mizunuma, Kentaro Yamazaki et al. · The Lancet Oncology · 2012 · 319 citations

Placebo-controlled Phase 2, Tas-102 Monotherapy, Gastrointestinal Oncology +9

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

K. Yamazaki, Michitaka Nagase, H Tamagawa et al. · Annals of Oncology · 2016 · 274 citations · Full text

Gastrointestinal Oncology, Medicine, Pharmacology +9

A randomized study of screening for ovarian cancer: a multicenter study in Japan

Hiroshi Kobayashi, Yasuhiro Yamada, Toshiyuki Sado et al. · International Journal of Gynecological Cancer · 2007 · 272 citations

Phase II study of NK105, a paclitaxel-incorporating micellar nanoparticle, for previously treated advanced or recurrent gastric cancer

Ken Kato, Keisho Chìn, Takaki Yoshikawa et al. · Investigational New Drugs · 2011 · 234 citations

Nanomedicine, Drug Targeting, Gastrointestinal Oncology +11

Ruthenium-catalyzed N-alkylation and N-benzylation of aminoarenes with alcohols

Yoshihisa Watanabe, Yasushi Tsuji, Hitoshi Ige et al. · The Journal of Organic Chemistry · 1984 · 216 citations

Derivative (Chemistry), Engineering, Donut Icon +11